Adsorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled SPD557 in Volunteers
Completed · Phase 1
Conditions studied: Healthy Volunteers
In brief
Phase I study to evaluate the excretion of radioactivity, the metabolic profile, pharmacokinetics, safety and tolerability following a single oral administration of \[14C\] SPD557 in healthy male volunteers aged 18 to 50 years (inclusive).The purpose of this study is to investigate how and how quickly SPD557 or its break down products are excreted by analysing blood, faeces and urine samples collected during the study.
Key facts
- Study ID
- NCT01786876
- Run by
- Shire
- People needed
- 6
- Starts
- 2013-03-07
- Expected to finish
- 2013-04-12
- Last updated by the study team
- 2021-06-10
Who can join
Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.
Where it is running
- Covance — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.